Royal Bank Of Canada Alnylam Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 411,066 shares of ALNY stock, worth $96 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

411,066

Previous 411,364 0.07%

Holding current value

$96 Million

Previous $100 Million 13.12%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $69,675 - $85,528	-298 Reduced 0.07%	411,066 $113 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $5.29 Million - $9.12 Million	36,940 Added 9.87%	411,364 $100 Million
Q1 2024 Nov 05, 2024	SELL	$146.51 - $198.2 $5.41 Million - $7.32 Million	-36,940 Reduced 8.98%	374,424 $56 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $17.1 Million - $23.1 Million	116,469 Added 45.15%	374,424 $56 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $2.1 Million - $2.72 Million	13,849 Added 5.67%	257,955 $49.4 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $361,349 - $447,851	-2,116 Reduced 0.86%	244,106 $43.2 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $5.56 Million - $6.37 Million	30,063 Added 13.91%	246,222 $46.8 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $3.58 Million - $4.61 Million	19,579 Added 9.96%	216,159 $43.3 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $24.2 Million - $31.5 Million	130,564 Added 197.78%	196,580 $46.7 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $2.09 Million - $3.5 Million	-15,087 Reduced 18.6%	66,016 $13.2 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $7.05 Million - $9.9 Million	58,508 Added 258.94%	81,103 $11.8 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $712,971 - $974,939	-5,606 Reduced 19.88%	22,595 $3.69 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $575,852 - $755,327	3,609 Added 14.68%	28,201 $4.78 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $1.44 Million - $1.76 Million	8,464 Added 52.48%	24,592 $4.64 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $2.07 Million - $2.85 Million	16,128 New	16,128 $2.73 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Alnylam Pharmaceuticals, Inc. Transaction History